The ECRG4 cleavage product augurin binds the endotoxin receptor and influences the innate immune response during otitis media.

Kurabi, Arwa; Hur, Dong Gu; Pak, Kwang; Gibson, Madeline; Webster, Nicholas J G; Baird, Andrew; Eliceiri, Brian P; Ryan, Allen F

Kurabi, Arwa; Hur, Dong Gu; Pak, Kwang; Gibson, Madeline; Webster, Nicholas J G; Baird, Andrew; Eliceiri, Brian P; Ryan, Allen F.

Afiliação

Kurabi A; Department of Otolaryngology, University of California, San Diego, La Jolla, CA, United States.
Hur DG; Department of Otolaryngology, University of California, San Diego, La Jolla, CA, United States.
Pak K; Department of Otorhinolaryngology, Gyeongsang National University Changwon Hospital, Changwon, South Korea.
Gibson M; Department of Otolaryngology, University of California, San Diego, La Jolla, CA, United States.
Webster NJG; Department of Otolaryngology, University of California, San Diego, La Jolla, CA, United States.
Baird A; Department of Medicine, University of California, San Diego, La Jolla, CA, United States.
Eliceiri BP; San Diego Veterans Administration Healthcare System, San Diego, CA, United States.
Ryan AF; Department of Surgery, University of California, San Diego, La Jolla, CA, United States.

Front Genet ; 13: 932555, 2022.

Article em En | MEDLINE | ID: mdl-36092940

Palavras-chave

ECRG4; NTHi; augurin; bacterial middle ear infection; growth suppression

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google